Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,366.50
Bid: 1,360.50
Ask: 1,361.50
Change: 61.00 (4.67%)
Spread: 1.00 (0.074%)
Open: 1,318.50
High: 1,366.50
Low: 1,309.50
Prev. Close: 1,305.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Persimmon Acts to Address Legacy Cladding Issues

10 Feb 2021 07:00

RNS Number : 5360O
Persimmon PLC
10 February 2021
 

10 February 2021

 

Persimmon plc

("Persimmon" or "the Group")

 

Persimmon Acts to Address Legacy Cladding Issues

 

Following a review of past projects, Persimmon is today announcing a financial commitment to address cladding safety issues in its legacy development portfolio.

 

As first and foremost a builder of traditional family homes, the Group has not been a major developer of high-rise buildings. We believe we account for less than one percent of all high-rise developments. However, in the past we have built multi-storey buildings which met all the fire safety rules and regulations in place at the time, but which used cladding materials which may now be considered unsafe and require removal.

 

The Group believes strongly that it has a responsibility to step forward and tackle this issue head-on. Persimmon has therefore made a provision of £75 million in its 2020 results to pay for our contribution to any necessary work on 26 buildings that may be affected by the cladding issue.

 

Persimmon has identified 9 high-rise buildings over 18 metres built by the Group where, in-line with government guidance, cladding may need to be removed. Persimmon does not own any of these buildings and the legal responsibility and duty to ensure the building is safe rests with the current owners. Persimmon will provide technical support to ensure the building is made safe. However, if a building owner fails to step up and accept their responsibilities, Persimmon stands ready to provide the support necessary to make sure the work is done.

 

For buildings below 18 metres in height the Government has recommended a risk-based approach. The Group has identified 17 buildings below 18 metres that may be fitted with cladding requiring detailed investigation. Where Persimmon owns the building it will, of course, lead this work. Where the Group no longer owns the building, it will support the owners and other parties in their efforts to ensure the buildings are safe for residents. Once again, should a building owner fail to meet their obligations, Persimmon stands ready to provide the support to make sure this happens.

The Group is in the process of writing to building owners and management companies ('Factors' in Scotland) to inform them of the findings of its review and to agree next steps. It is the Group's intention to progress matters as swiftly as possible, minimising uncertainty and concern for residents.

 

Roger Devlin, Chairman of Persimmon, said: "The concern around now banned cladding is affecting many thousands of homeowners who live in high-rise buildings right across the country.

 

"At Persimmon we believe we have a clear duty to act to address this issue. So today we are setting aside £75 million towards any necessary cladding remediation and safety work in 26 developments we built. Where we still own the building we will act. Where we no longer own them we will work with the owners to make sure they meet their legal responsibilities and duty. If the owner does not step up then we will act to remove uncertainty and anxiety for residents and make the buildings safe.

 

"This is a decision which we believe is not only right for residents but also the right thing for us to do as one of the leading housebuilders in the UK. We want Persimmon to be a business with a long-term, responsible and sustainable future and hope our actions today demonstrate a clear commitment to these values."

 

Notes

We have established a dedicated national Freephone helpline number - 0800 915 0100 - which residents can call for more information. Alternatively, details can be registered via a webpage: www.persimmonhomes.com/claddingenquiries

 

For further information, please contact:

 

Persimmon

Anthony Vigor, Group Director of Policy and External Affairs

Tel: +44 (0)7767 425822

 

Citigate Dewe Rogerson

Kevin Smith / Jos Bieneman

Tel: +44 (0)20 7638 9571

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKSKRAAUURAR
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.